Expression of innate and other adaptive immune genes, including GFAP for activated astrocytes and IBA-1 for microgliosis, were comparable between IDH1R132H and IDH1-wild-type gliomas (Supplementary Fig. S4A–E). This evidence concerns the gene GFAP and central nervous system cancer.